CPL304110
CPL304110 is a potent, orally active and selective inhibitor of fibroblast growth factor receptors FGFR (1-3), with IC50 values of 0.75 nM, 0.5 nM, and 3.05 nM for FGFR (1-3), respectively[1].
Product Specifications
CAS Number
1627826-19-0
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cpl304110.html
Purity
99.85
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CN(CC1)CCN1C2=CC3=C(N=C(C4=NNC(CCC5=CC(OC)=CC(OC)=C5)=C4)N3)C=C2
Molecular Formula
C25H30N6O2
Molecular Weight
446.54
References & Citations
[1]Abdellah Yamani, et al. Discovery and optimization of novel pyrazole-benzimidazole CPL304110, as a potent and selective inhibitor of fibroblast growth factor receptors FGFR (1-3) . Eur J Med Chem. 2020 Nov 7;112990.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![5-[ (4-chlorophenyl) amino]-5-oxopentanoic acid](https://cdn.genprice.uk/genprice/uk/genprice3.webp)
T5048-02 10 µg
Thrombomodulin, Recombinant, Human (CD141, TM, Fetomodulin)
Sign In for Pricing
View Details 